SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

PolyPid Provides Corporate Update and Reports Third Quarter 2026 Financial Results

D-PLEX₁₀₀ NDA Under FDA Priority Review with PDUFA Goal Date of November 28, 2026; U.S. Commercial L

PYPD

Related stories